C

Clinuvel Pharmaceuticals
CUV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$567.11M
EV
A$369.61M
Shares Outstanding
50.01M
Beta
0.82

Wall Street View

Analyst Rating
BUY
Analyst Target Price
A$24.63
P/E 2025E
14.70x
P/Revenue 2025E
5.77x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Clinuvel Pharmaceuticals Limited

gainify

C

Clinuvel Pharmaceuticals Limited

CUV

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally...

Sector

Healthcare

Industry

Biotechnology

CEO

Wolgen, Philippe

Employees

16

IPO Date

2001-02-11

Headquarters

535 Bourke Street, Level 22, Melbourne, Victoria, 3000, Australia

gainify
mailcontactcontact
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.